###begin article-title 0
Role of acid-sensing ion channel 3 in sub-acute-phase inflammation
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 386 392 386 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3 </italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 407 410 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
Inflammation-mediated hyperalgesia involves tissue acidosis and sensitization of nociceptors. Many studies have reported increased expression of acid-sensing ion channel 3 (ASIC3) in inflammation and enhanced ASIC3 channel activity with pro-inflammatory mediators. However, the role of ASIC3 in inflammation remains inconclusive because of conflicting results generated from studies of ASIC3 knockout (ASIC3-/-) or dominant-negative mutant mice, which have shown normal, decreased or increased hyperalgesia during inflammation.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 119 123 119 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 312 317 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 317 321 317 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 336 340 336 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 700 705 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 716 723 716 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 849 854 849 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 854 858 854 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 861 866 861 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 866 870 866 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 964 969 964 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 969 973 969 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1013 1018 1013 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1018 1022 1018 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1161 1166 1161 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1166 1170 1166 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 167 170 <span type="species:ncbi:31658">CFA</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 425 428 <span type="species:ncbi:31658">CFA</span>
###xml 596 599 <span type="species:ncbi:31658">CFA</span>
###xml 799 802 <span type="species:ncbi:31658">CFA</span>
###xml 870 874 <span type="species:ncbi:10090">mice</span>
###xml 973 977 <span type="species:ncbi:10090">mice</span>
###xml 1022 1026 <span type="species:ncbi:10090">mice</span>
###xml 1080 1083 <span type="species:ncbi:31658">CFA</span>
###xml 1170 1174 <span type="species:ncbi:10090">mice</span>
Here, we tested whether ASIC3 plays an important role in inflammation of subcutaneous tissue of paw and muscle in ASIC3-/- mice induced by complete Freund's adjuvant (CFA) or carrageenan by investigating behavioral and pathological responses, as well as the expression profile of ion channels. Compared with the ASIC3+/+ controls, ASIC3-/- mice showed normal thermal and mechanical hyperalgesia with acute (4-h) intraplantar CFA- or carrageenan-induced inflammation, but the hyperalgesic effects in the sub-acute phase (1-2 days) were milder in all paradigms except for thermal hyperalgesia with CFA-induced inflammation. Interestingly, carrageenan-induced primary hyperalgesia was accompanied by an ASIC3-dependent Nav1.9 up-regulation and increase of tetrodotoxin (TTX)-resistant sodium currents. CFA-inflamed muscle did not evoke hyperalgesia in ASIC3-/- or ASIC3+/+ mice, whereas carrageenan-induced inflammation in muscle abolished mechanical hyperalgesia in ASIC3-/- mice, as previously described. However, ASIC3-/- mice showed attenuated pathological features such as less CFA-induced granulomas and milder carrageenan-evoked vasculitis as compared with ASIC3+/+ mice.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
We provide a novel finding that ASIC3 participates in the maintenance of sub-acute-phase primary hyperalgesia in subcutaneous inflammation and mediates the process of granuloma formation and vasculitis in intramuscular inflammation.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
Inflammation, the complex reaction of the body to harmful stimuli, is often accompanied by redness, swelling, pain and heat. During inflammation, damaged tissues release pro-inflammatory mediators such as bradykinin, serotonin, histamine, nerve growth factor, prostaglandin, neuropeptides and cytokines to activate immune cells and neurons [1]. These factors serve a protective purpose by stimulating the immune system, which causes vasodilatation to allow the exudation of plasma and leukocytes into the surrounding tissues, whereby the harmful stimuli are removed and the injured tissue undergoes repairing. The extravasation of leukocytes and plasma fluid into the tissue accounts for the swelling of the tissue, whereas the increased blood flow is responsible for the heat and redness.
###end p 9
###begin p 10
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 320 321 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 369 374 <span type="species:ncbi:9606">human</span>
Inflammation also causes tissue acidosis, whereby high concentrations of protons are the direct cause of pain [2,3]. Acid-sensing ion channel 3 (ASIC3) is the most sensitive nociceptive ion channel responding to tissue acidosis [3,4]. During inflammation, lactic acid, arachidonic acid and nitric oxide sensitize ASIC3 [5-7]. Up-regulation of ASIC3 is seen in inflamed human intestine [8] and dorsal root ganglia (DRG) of rodents with inflamed hind paws [9,10].
###end p 10
###begin p 11
###xml 182 208 182 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 859 864 859 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 864 868 864 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 967 969 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1135 1137 1135 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 111 114 <span type="species:ncbi:31658">CFA</span>
###xml 182 208 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 358 361 <span type="species:ncbi:31658">CFA</span>
###xml 868 872 <span type="species:ncbi:10090">mice</span>
Two experimental models of inflammation have been widely used in research of pain. Complete Freund's adjuvant (CFA) is composed of an antigen solution of heat-inactivated bacterium, Mycobacterium tuberculosis, emulsified in mineral oil, which can potentiate the cell-mediated immune response and the production of immunoglobulins [11]. A single injection of CFA into the plantar surface of the paw induces intense and persistent inflammation at local injection sites and occasionally at distant locations because of its systemic spread [12]. In contrast, carrageenan is thought to produce non-immune-mediated inflammation [13]. A subcutaneous injection of carrageenan induces inflammatory responses initially mediated by mast cells and neutrophils, and then followed by a phagocytic response, which depends on the mobilization of macrophages. The behavior of ASIC3-/- mice has been studied largely with the carrageenan inflammation model but with discrepant results [14-17]. Interestingly, these previous studies imply that ASIC3 might be involved in the development of secondary but not primary hyperalgesia produced by inflammation [16,17].
###end p 11
###begin p 12
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 360 364 360 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 368 373 368 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 373 377 373 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 310 313 <span type="species:ncbi:31658">CFA</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
Sensory neurons innervating muscle and those innervating skin are considered to have different properties, and ASIC3 is more likely expressed in the former than in the latter [18]. To reveal the functional role of ASIC3 in inflammation, we systematically studied thermal and mechanical hyperalgesia induced by CFA and carrageenan in the paw and muscle of ASIC3+/+ and ASIC3-/- mice. Tissue underwent pathological examination and real-time PCR to reveal the gene regulation of ion channels dependent on ASIC3 following inflammation.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Behavior tests
###end title 14
###begin p 15
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 5 9 5 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 18 22 18 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
ASIC3+/+ and ASIC3-/- mice did not differ in baseline responses to thermal and mechanical stimuli or responses in left and right paws. No hyperalgesic effect was observed on the contralateral sides of the injections at most times during this study (Additional file 1).
###end p 15
###begin p 16
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 44 48 44 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 57 61 57 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 234 238 234 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 247 251 247 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 513 518 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 518 522 518 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 531 535 531 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 610 615 610 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 615 619 615 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 759 764 759 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 764 768 764 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 842 847 842 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 847 851 847 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 100 103 <span type="species:ncbi:31658">CFA</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
Thermal hyperalgesia developed in both ASIC3+/+ and ASIC3-/- mice as soon as 4 h after injection of CFA or carrageenan into paws of both genotypes (Fig. 1A), which persisted for 7 days for both inflammatory models. Although both ASIC3+/+ and ASIC3-/- mice showed increased sensitivity to heat, the latter showed longer withdrawal latency from 4 h to 2 days than the former in the carrageenan inflammatory model. The difference was small but significant after 4 h, with a mean latency of 3.20 sec and 2.09 sec for ASIC3-/- and ASIC3+/+ mice, respectively (P < 0.05). On days 1 and 2, paw withdrawal latency for ASIC3+/+ mice remained short (mean latency 2.49 sec for day 1 and 2.66 sec for day 2), but the magnitude of hyperalgesia was significantly lower for ASIC3-/- mice (mean latency 4.44 sec for day 1 and 5.96 sec for day 2 than that of ASIC3+/+ mice (P < 0.05).
###end p 16
###begin p 17
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intraplantar inflammation-mediated hyperalgesia</bold>
###xml 83 84 83 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 113 114 113 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 149 153 149 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 189 193 189 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 329 333 329 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 342 346 342 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 354 357 <span type="species:ncbi:31658">CFA</span>
Intraplantar inflammation-mediated hyperalgesia. Results of ipsilateral side only. A, Thermal hyperalgesia test. B, von Frey filament test. WT: ASIC3+/+ mice, n = 6 in each group. KO: ASIC3-/- mice, n = 6 or 7 in each group. *p < 0.05, **p < 0.01, ***p < 0.001 compared to baseline. #p < 0.05, ##P < 0.01 comparison between ASIC3+/+ and ASIC3-/- groups. CFA = complete Freund's adjuvant
###end p 17
###begin p 18
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 13 17 13 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 26 30 26 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 270 274 270 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 292 296 292 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 347 352 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 352 356 352 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 429 434 429 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 434 438 434 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 492 497 492 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 497 501 497 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 505 510 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 510 514 510 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 645 649 645 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 709 714 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 714 718 714 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 734 739 734 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 739 743 739 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 822 827 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 827 831 827 831 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 149 152 <span type="species:ncbi:31658">CFA</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 366 369 <span type="species:ncbi:31658">CFA</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
###xml 718 722 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
Neither ASIC3+/+ nor ASIC3-/- mice showed a response to von Frey filaments following saline injection, but both developed mechanical hyperalgesia in CFA and carrageenan inflammatory models; however, the mechanical hyperalgesia was much milder and more transient in ASIC3-/- mice than in ASIC3+/+ mice (Fig 1B). Of 5 applications of the filaments, ASIC3+/+ mice with CFA-inflamed paws responded 3-4 times on days 1 and 2, whereas ASIC3-/- mice responded only 1-2 times and only on day 1. Both ASIC3+/+ and ASIC3-/- mice with carrageenan-induced inflammation showed hyperalgesia at a comparable level at 4 hr after injection. Hyperalgesia in ASIC3+/+ mice continued to increase on days 1 and 2 but decreased in ASIC3-/- mice. On day 7, ASIC3+/+ mice still showed mechanical hyperalgesia as compared with at baseline but not ASIC3-/- mice.
###end p 18
###begin p 19
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3 </italic>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 440 445 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 445 449 445 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 697 702 697 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 702 706 702 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 744 749 744 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 749 753 749 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 75 78 <span type="species:ncbi:31658">CFA</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 523 526 <span type="species:ncbi:31658">CFA</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
To test whether the ASIC3 gene plays a role in intramuscular inflammation, CFA or carrageenan was injected into gastrocnemius muscle. Then thermal and mechanical tests were applied to the ipsilateral paw, not the inflammatory muscular site, to measure the effect of secondary hyperalgesia. Muscular inflammation had no effect on paw sensitivity to heat stimuli in both genotypes of mice, regardless of the inflammatory agents (Fig. 2A). In ASIC3+/+ mice, no significant increase in mechanical sensitivity was observed with CFA-induced inflammation throughout the test period or carrageenan-induced inflammation on day 1. However, mechanical hyperalgesia developed on day 2 in carrageenan-injected ASIC3+/+ mice (Fig. 2B) but did not develop in ASIC3-/- mice.
###end p 19
###begin p 20
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intramuscular inflammation-mediated hyperalgesia</bold>
###xml 84 85 84 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 114 115 114 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 150 154 150 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 190 194 190 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 288 292 288 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 301 305 301 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 313 316 <span type="species:ncbi:31658">CFA</span>
Intramuscular inflammation-mediated hyperalgesia. Results of ipsilateral side only. A, Thermal hyperalgesia test. B, von Frey filament test. WT: ASIC3+/+ mice, n = 6 in each group. KO: ASIC3-/- mice, n = 6 in each group. **p < 0.01 compared to baseline. #p < 0.05 comparison between ASIC3+/+ and ASIC3-/- groups. CFA = complete Freund's adjuvant
###end p 20
###begin p 21
###xml 440 445 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 445 449 445 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 791 796 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 796 800 796 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 804 809 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 809 813 809 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1021 1022 1021 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1024 1025 1024 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1138 1142 1138 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C&#8211;F</xref>
###xml 1150 1154 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C&#8211;F</xref>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 672 675 <span type="species:ncbi:31658">CFA</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 1010 1014 <span type="species:ncbi:10090">mice</span>
Examination of pathological specimensTo associate the previously mentioned behavioral changes induced by pain as a result of inflammatory states in these mice, we performed histopathological examination of tissue changes in these samples. For intraplantar injections, remarkable paw edema and redness occurred as soon as 4 h after injection and persisted for 7 days, with variations in the appearance of these inflammatory sites. In 2 of 6 ASIC3+/+ mice injected with carrageenan, the inflammation was so severe that black bruises, indicative of subcutaneous hemorrhage in the paw, became evident. Measurement of paw thickness 4 h and 2 and 7 days after the injections of CFA or carrageenan showed significant swelling, with carrageenan causing swelling at all time points (Fig. 3); however ASIC3+/+ and ASIC3-/- mice did not differ in paw thickness. Histological examination revealed edema and mixed inflammatory infiltration composed of neutrophils and mononuclear inflammatory cells in paw sections of both mice (Fig. 4 &5). The inflammatory infiltration was evident at all time points but was milder at 4 h than at days 2 and 7 (Fig. 4C-F & Fig. 5C-F).
###end p 21
###begin p 22
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Paw edema following the induction of inflammation</bold>
###xml 180 181 180 181 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 227 228 227 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 264 265 264 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 310 314 310 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 345 350 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 350 354 350 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 158 161 <span type="species:ncbi:31658">CFA</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 512 515 <span type="species:ncbi:31658">CFA</span>
Paw edema following the induction of inflammation. Measurement of thickness of ipsilateral paws swelled with inflammation by both complete Freund's adjuvant (CFA) and carrageenan. A, Thickness 4 h after intraplantar injection. B, Thickness 2 days after injection. C, Thickness 7 days after injection. WT: ASIC3+/+ mice, n = 6 in each group. KO: ASIC3-/- mice, n = 6 in each group. *p < 0.05, **p < 0.01, ***p < 0.001 compared with the saline control group. #p < 0.05, ##p < 0.01, ###p < 0.001 comparison between CFA and carrageenan in the same genotype group.
###end p 22
###begin p 23
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H&amp;E sections of CFA-inflamed hind paws</bold>
###xml 133 134 133 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 149 154 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 154 158 154 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 177 178 177 178 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 198 202 198 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 220 221 220 221 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 236 241 236 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 241 245 241 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 263 264 263 264 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 279 284 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 284 288 284 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 307 308 307 308 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 328 332 328 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 350 351 350 351 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 371 375 371 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 16 19 <span type="species:ncbi:31658">CFA</span>
###xml 128 131 <span type="species:ncbi:31658">CFA</span>
###xml 136 139 <span type="species:ncbi:31658">CFA</span>
###xml 180 183 <span type="species:ncbi:31658">CFA</span>
###xml 223 226 <span type="species:ncbi:31658">CFA</span>
###xml 266 269 <span type="species:ncbi:31658">CFA</span>
###xml 310 313 <span type="species:ncbi:31658">CFA</span>
###xml 353 356 <span type="species:ncbi:31658">CFA</span>
H&E sections of CFA-inflamed hind paws. Representative H&E sections obtained 4 hr, 2 and 7 days after intraplantar injection of CFA. A, CFA-inflamed ASIC3+/+ hind paw on day 2. B, CFA-inflamed ASIC3-/- hind paw on day 2.C, CFA-inflamed ASIC3+/+ hind paw at 4 hr. D, CFA-inflamed ASIC3+/+ hind paw on day 7. E, CFA-inflamed ASIC3-/- hind paw at 4 hr. F, CFA-inflamed ASIC3-/- hind paw on day 7. Neutrophils are indicated by black arrows.
###end p 23
###begin p 24
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H&amp;E sections of carrageenan-inflamed hind paws</bold>
###xml 149 150 149 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 178 182 178 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 201 202 201 202 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 230 234 230 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 253 254 253 254 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 282 286 282 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 304 305 304 305 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 334 338 334 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 357 358 357 358 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 381 386 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 386 390 386 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 408 409 408 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 432 437 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 437 441 437 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
H&E sections of carrageenan-inflamed hind paws. Representative H&E sections obtained 4 hr, 2 and 7 days after intraplantar injection of carrageenan. A, Carrageenan-inflamed ASIC3+/+ hind paw on day 2. B, Carrageenan-inflamed ASIC3-/- hind paw on day 2. C, Carrageenan-inflamed ASIC3+/+ hind paw at 4 hr. D, Carrageenan -inflamed ASIC3+/+ hind paw on day 7. E, Carrageenan-inflamed ASIC3-/- hind paw at 4 hr. F, Carrageenan-inflamed ASIC3-/- hind paw on day 7. Neutrophils are indicated by black arrows and mononuclear cells are indicated by yellow arrows.
###end p 24
###begin p 25
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 992 994 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E</xref>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6F</xref>
###xml 1015 1031 1015 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1248 1253 1248 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1253 1257 1253 1257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1267 1269 1267 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E</xref>
###xml 1308 1313 1308 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1313 1317 1313 1317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1355 1357 1355 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6F</xref>
###xml 1411 1413 1409 1411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1417 1422 1415 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1422 1426 1420 1424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1451 1453 1447 1449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1457 1462 1453 1458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1462 1466 1458 1462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1488 1490 1484 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 1530 1535 1526 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1535 1539 1531 1535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1584 1589 1580 1585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1589 1593 1585 1589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1720 1724 1716 1720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B&#8211;D</xref>
###xml 1868 1874 1864 1870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3 </italic>
###xml 62 65 <span type="species:ncbi:31658">CFA</span>
###xml 603 606 <span type="species:ncbi:31658">CFA</span>
###xml 854 857 <span type="species:ncbi:31658">CFA</span>
###xml 1001 1004 <span type="species:ncbi:31658">CFA</span>
###xml 1015 1030 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1257 1261 <span type="species:ncbi:10090">mice</span>
###xml 1317 1321 <span type="species:ncbi:10090">mice</span>
###xml 1426 1430 <span type="species:ncbi:10090">mice</span>
###xml 1466 1470 <span type="species:ncbi:10090">mice</span>
###xml 1539 1543 <span type="species:ncbi:10090">mice</span>
###xml 1593 1597 <span type="species:ncbi:10090">mice</span>
###xml 1820 1823 <span type="species:ncbi:31658">CFA</span>
Gross examination of the injection sites of normal saline and CFA was unremarkable, but large areas of hemorrhage could be seen in carrageenan-induced inflamed muscles after skin was removed on day 2. Histologically, the muscle sections of saline groups revealed intact and well-organized muscular fibers, connective tissue and vascular channels with mild infiltration of leukocytes found along the needle tracks in some cases (Fig. 6A). However, marked infiltration of mononuclear inflammatory cells (most likely macrophages) and edema evidenced by the spaces between muscular fibers was observed with CFA injection (Fig. 6B &6C). The inflammatory cells infiltrated endomysial and perimysial connective tissue and caused focal destruction of the myocytes (Fig. 6D). Large round to oval empty spaces representing the deposition of the lipid content from CFA were frequently surrounded by inflammatory infiltrates and the formation of granulomas with epithelioid macrophages was evident (Fig. 6E &6F). CFA contained M. tuberculosis and mineral oil, which might well account for the formation of granulomas from day 2. Well-formed granulomas defined by compact, well-circumscribed structures composed of epitheloid macrophages were characteristic of ASIC3+/+ mice (Fig 6E), but most of the granulomas found in ASIC3-/- mice were small and ill-defined (Fig. 6F). The mean density of granulomas was 0.80 +/- 0.23/mm2 for ASIC3+/+ mice and 0.24 +/- 0.08/mm2 for ASIC3-/- mice (p < 0.05) (Fig. 7A). In parallel of this, the myocytes in ASIC3+/+ mice showed more severe damage than those in ASIC3-/- mice, with more myocytes exhibiting variation in fiber size, centrally located nuclei and invasion by inflammatory cells (Fig. 6B-D). These data indicate that the inflammatory response and subsequent muscular damage induced by CFA injection were milder in the absence of the ASIC3 gene.
###end p 25
###begin p 26
###xml 0 19 0 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CFA-inflamed muscle</bold>
###xml 93 94 93 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 127 128 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 148 152 148 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 309 310 309 310 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 330 334 330 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 342 343 342 343 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 401 405 401 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 537 538 537 538 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 593 598 593 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 598 602 598 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 610 611 610 611 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 668 673 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 673 677 673 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 3 <span type="species:ncbi:31658">CFA</span>
###xml 130 133 <span type="species:ncbi:31658">CFA</span>
###xml 312 315 <span type="species:ncbi:31658">CFA</span>
###xml 383 386 <span type="species:ncbi:31658">CFA</span>
###xml 580 583 <span type="species:ncbi:31658">CFA</span>
###xml 655 658 <span type="species:ncbi:31658">CFA</span>
CFA-inflamed muscle. Representative H&E sections obtained 2 days after induced inflammation. A, Normal control muscle section. B, CFA-inflamed ASIC3+/+ muscle. Myocytes were separated and rounded up with leukocytes migrated into the intercellular space. Lipid drops surrounded by mononuclear cells were seen. C, CFA-inflamed ASIC3-/- muscle. D, A higher magnitude picture taken from CFA-inflamed ASIC3+/+ muscle. Black arrow shows a myocyte being invaded by mononuclear cells. White arrow indicates the centralized nucleus in a myocyte. E, Well-formed granulomas (black arrow) in CFA-inflamed ASIC3+/+ muscle. F, An ill-defined granuloma (black arrow) in CFA-inflamed ASIC3-/- muscle.
###end p 26
###begin p 27
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 54 58 54 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 67 71 67 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of inflammatory features of muscle of <italic>ASIC3</italic><sup>+/+ </sup>and <italic>ASIC3</italic><sup>-/- </sup>mice at day 2</bold>
###xml 86 87 86 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 155 159 155 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 182 186 182 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 205 206 205 206 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 296 300 296 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 321 326 321 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 326 330 326 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
Comparison of inflammatory features of muscle of ASIC3+/+ and ASIC3-/- mice at day 2. A, Density of well-formed granuloma was significantly higher in ASIC3+/+ (WT) mice than in ASIC3-/- (KO) mice (n = 4). B, The proportion of vasculitic vessels to total vessels was significantly greater in ASIC3+/+ mice (n = 4) than in ASIC3-/- mice (n = 5). *p < 0.05
###end p 27
###begin p 28
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 389 393 389 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 402 406 402 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8E</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 1029 1034 1029 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1034 1038 1034 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1051 1056 1051 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1056 1060 1056 1060 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1100 1102 1100 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 1038 1042 <span type="species:ncbi:10090">mice</span>
###xml 1060 1064 <span type="species:ncbi:10090">mice</span>
Injection of carrageenan produced a different type of histopathology. Carrageenan appeared as an amorphous pink substance permeating the intercellular space, which induced inflammatory infiltration and extravasation of red blood cells or hemorrhage in severe cases. Inflammatory infiltration into the muscle and subcutaneous fat lobules caused rhabdomyolysis and panniculitis in both ASIC3+/+ and ASIC3-/- mice (Fig. 8A &8D). Interestingly, inflammatory infiltration was also seen in some of the vascular walls and caused vascular wall destruction or vasculitis (Fig. 8B &8E). The lining of endothelial cells appeared prominent in the damaged areas. Small black granules or nuclear dusts within the disrupted vascular walls were also noted (Fig. 8B &8C). Carrageenan-induced vasculitis might be responsible for the hemorrhage described earlier and contributed to rhabdomyolysis. Interestingly, vasculitis was observed only within veins in this model. Also, the proportion of vessels affected by vasculitis seemed to be higher in ASIC3+/+ mice than in ASIC3-/- mice (69.02% vs. 31.13% P < 0.05) (Fig. 7B).
###end p 28
###begin p 29
###xml 0 27 0 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Carrageenan-inflamed muscle</bold>
###xml 107 110 107 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-C</bold>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 135 139 135 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 145 146 145 146 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 174 178 174 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 256 257 256 257 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 299 303 299 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 388 389 388 389 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 429 430 429 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 536 539 536 539 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D-F</bold>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 564 568 564 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 574 575 574 575 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 603 607 603 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 615 616 615 616 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 698 702 698 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 710 711 710 711 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 751 752 751 752 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
Carrageenan-inflamed muscle. Representative H&E sections were obtained 2 days after carrageenan injection. A-C, H&E sections from ASIC3+/+ mice. A, Carrageenan-inflamed ASIC3+/+ muscle. Carrageenan filled in the intercellular matrix, causing inflammation. B, Vasculitis in carrageenan-inflamed ASIC3+/+ muscle. The arterial wall (right) was intact, but the vein (left) showed vasculitis. C, Higher magnitude of bracket area from B. Black granules were deposited on the vascular wall (arrows) and the lining of the lumen was incomplete. D-F, H&E sections from ASIC3-/- mice. D, Carrageenan-inflamed ASIC3-/- muscle. E, Vein (right) and artery (left) remained integrated in carrageenan-inflamed ASIC3-/- muscle. F, Higher magnitude of bracket area from E.
###end p 29
###begin p 30
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A&#8211;G</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9H&#8211;K</xref>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9L&#8211;O</xref>
###xml 410 413 <span type="species:ncbi:31658">CFA</span>
To further identify the precise location of ASIC3-containing afferents in inflamed sites, we stained frozen muscle sections with antibodies against ASIC3 and PGP9.5, which is an ubiqutin C-terminal hydrolase specifically expressed in most neurons [19]. We first confirmed that the ASIC3 immunoreactivity was found in vessels and nerve bundles in non-inflamed areas as previously described (Fig. 9A-G) [18]. In CFA-inflamed muscle, no obvious ASIC3 or PGP9.5 immunoreactivities were found in areas surrounding granuloma (Fig. 9H-K). In contrast, in carrageenan-inflamed muscle, the location of ASIC3 immunoreactivity was often found on vessels with vasuclitis (Fig. 9L-O).
###end p 30
###begin p 31
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3-containing afferents in inflamed muscle</bold>
###xml 148 155 148 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, B, C</bold>
###xml 250 260 250 260 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D, E, F, G</bold>
###xml 349 350 349 350 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 353 363 353 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H, I, J, K</bold>
###xml 438 448 438 448 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L, M, N, O</bold>
###xml 529 539 529 539 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, D, H, L</bold>
ASIC3-containing afferents in inflamed muscle. Red labeling shows secondary antibodies conjugated with Alexa Fluor-594, green with Alexa Fluor-488. A, B, C, ASIC3 immunoreactive nerves were found surrounding the vessels and co-localized with PGP9.5. D, E, F, G, In nerve bundles, ASIC3 immunoreactivity was co-localized with PGP9.5 (yellow spots in G). H, I, J, K, ASIC3 and PGP9.5 had no immunoreactivity in areas surrounding granuloma. L, M, N, O, ASIC3 and PGP9.5 immunoreactive nerves were found on a vessel with vasculitis. A, D, H, L, shows the contrast pictures. Yellow or black arrows indicate the co-localization of ASIC3 and PGP9.5; the red arrow indicates positive staining for PGP9.5 but not ASIC3. The arrowhead shows a well-formed granuloma.
###end p 31
###begin title 32
Gene expression in DRG
###end title 32
###begin p 33
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.6</italic>
###xml 133 139 133 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.7</italic>
###xml 141 147 141 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8</italic>
###xml 149 156 149 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRPV1 </italic>
###xml 180 186 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
To investigate which genes might be involved in the development of hyperalgesia, we examined the transcript levels of ASIC3, Nav1.6, Nav1.7, Nav1.8, Nav1.9 and TRPV1 normalized to GAPDH in DRGs of mice 2 days after inflammation induction.
###end p 33
###begin p 34
###xml 3 8 3 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 8 12 8 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 272 278 268 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 338 345 334 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 505 512 501 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 551 558 547 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 572 577 568 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 577 581 573 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 639 644 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 644 648 640 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 679 681 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 702 709 698 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 736 741 732 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 741 745 737 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 787 792 783 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 792 796 788 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 381 384 <span type="species:ncbi:31658">CFA</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
In ASIC3+/+ mice, only Nav1.9 was up-regulated 2 days after intraplantar carrageenan-induced inflammation (Fig. 10 & Additional file 2). Nav1.9 expression with carrageenan injection was significantly increased by twofold as compared with saline injection (mean DeltaCT to GAPDH 3.36 cycles vs. 1.98 cycles, P < 0.05). No up-regulation of Nav1.9 could be found in DRGs of mice with CFA-induced inflamed paws and the muscle inflammation models (Additional file 2). This carrageenan-induced up-regulation of Nav1.9 was also ASIC3 dependent. In contrast, Nav1.9 expression in ASIC3-/- mice treated with carrageenan did not differ from that in ASIC3-/- mice treated with saline (Fig. 10). The expression of Nav1.9 in the carrageenan-treated ASIC3-/- group was significantly lower than in the ASIC3+/+ group (p < 0.05).
###end p 34
###begin p 35
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 0 123 0 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Nav1.9 </italic>expression in L5 dorsal root ganglia (DRG) 4 hr and 2 and 7 days after intraplantar carrageenan-induced inflammation</bold>
###xml 125 132 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
Nav1.9 expression in L5 dorsal root ganglia (DRG) 4 hr and 2 and 7 days after intraplantar carrageenan-induced inflammation. Nav1.9 mRNA from the ipsilateral DRG quantified by real-time PCR and normalized to GADPH. (*p < 0.05, n = 3 or 4).
###end p 35
###begin title 36
TTX-resistant sodium currents in DRG neurons
###end title 36
###begin p 37
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3 </italic>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 345 352 345 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8 </sub>
###xml 387 394 387 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </sub>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 430 435 430 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 435 439 435 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 447 454 447 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8 </sub>
###xml 463 470 463 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </sub>
###xml 594 597 594 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11A</xref>
###xml 599 602 599 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11C</xref>
###xml 710 715 710 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 715 719 715 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 731 734 731 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11B</xref>
###xml 736 739 736 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11D</xref>
To investigate whether null mutation of ASIC3 affects the neuronal excitability in DRG neurons during carrageenan-induced inflammation, we conducted whole-cell patch recording to measure the tetrodotoxin (TTX)-resistant (TTX-R) sodium currents (Fig. 11). In small DRG neurons, TTX-R sodium currents are composed of two distinct components: the INav1.8 activated at about -40 mV and the INav1.9 activated about -60 mV [20]. In the ASIC3+/+ group, INav1.8 but not INav1.9 was significantly increased in small-to-medium DRG neurons 2 days after intraplantar carrageenan-induced inflammation (Fig. 11A &11C). However, intraplantar inflammation did not alter the amplitudes of both TTX-R currents in neurons of the ASIC3-/- group (Fig. 11B &11D).
###end p 37
###begin p 38
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Tetrodotoxin (TTX)-resistant sodium currents in lumbar DRG neurons</bold>
###xml 68 69 68 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 115 119 115 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 165 171 165 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8</sub>
###xml 252 259 252 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </sub>
###xml 316 317 316 317 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 358 363 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 363 367 363 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 373 374 373 374 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 418 423 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 423 427 423 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 433 434 433 434 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 478 483 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 483 487 483 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
Tetrodotoxin (TTX)-resistant sodium currents in lumbar DRG neurons. A, Representative TTX-R current traces in ASIC3+/+ mice. The TTX-R currents mediated by Nav1.8 (INav1.8) were induced by membrane depolarization from -80 to -40 mV; TTX-R currents of INav1.9 were induced membrane depolarization from -80 to -60 mV. B, Representative TTX-R current traces in ASIC3-/- mice. C, Mean peak amplitudes of TTX-R currents in ASIC3+/+ mice. D, Mean peak amplitudes of TTX-R currents in ASIC3-/- mice. The number of experiments (n) is indicated above each bar. **P < 0.01.
###end p 38
###begin title 39
Discussion
###end title 39
###begin title 40
Intraplantar inflammation
###end title 40
###begin p 41
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 63 67 63 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 382 388 382 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3 </italic>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 969 974 969 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 974 978 974 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1230 1235 1230 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1235 1239 1235 1239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1507 1509 1507 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1510 1512 1510 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1811 1813 1811 1813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1957 1962 1957 1962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1962 1966 1962 1966 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2077 2082 2077 2082 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 2082 2086 2082 2086 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 2092 2094 2092 2094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 144 149 <span type="species:ncbi:10090">mouse</span>
###xml 388 403 <span type="species:ncbi:10090">transgenic mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 978 982 <span type="species:ncbi:10090">mice</span>
###xml 1239 1243 <span type="species:ncbi:10090">mice</span>
###xml 1966 1970 <span type="species:ncbi:10090">mice</span>
###xml 2086 2090 <span type="species:ncbi:10090">mice</span>
Previous studies found that on intraplantar inflammation, ASIC3-/- mice exhibited either no or slightly enhanced hyperalgesia [14,15]. Although mouse strains and sexes of these two studies may cause the discrepant results from our current work, the studies used 2% carrageenan, and the tests were carried out only 3-4 h after injection. In another study involving dominant-negative ASIC3 transgenic mice [21], behavior tests were performed 1-6 h after zymosan injections to induce paw inflammation. These mice exhibited increased mechanical hypersensitivity. Although the role of ASIC3 in the acute phase of inflammation is inconclusive, our results indicate the involvement of ASIC3 in the sub-acute phase of inflammation. Our study showed no difference in nociceptive behaviors in the acute phase of inflammation (4 h) between two genotypes, except for a small but significant difference in thermal hyperalgesia in the carrageenan inflammatory model. On follow-up in ASIC3-/- mice, in both models for mechanical hyperalgesia and in the carrageenan model for thermal hyperalgesia, hyperalgesia was attenuated after intraplantar injection. The inflammation state might have changed from an acute to a sub-acute phase in 24 h, and ASIC3-/- mice could have recovered faster from hyperalgesia. Although ASIC3 is believed to play a more important role in secondary hyperalgesia (hypersensitivity occurred in non-injured sites) induced by inflamed muscle or joints than primary hyperalgesia in inflamed tissues [16,17], in this study we provide evidence that ASIC3 does play a role in subcutaneous primary hyperalgesia in later stages. This conclusion is also supported by a recent report showing that subcutaneous injection of the ASIC3-selective blocker APETx2 can alleviate the inflammation-induced hyperalgesia [22]. However, the role of ASIC3 for sub-acute-phase primary hyperalgesia is not applied to the deep tissues, because a recent study reported that ASIC3-/- mice did not show different levels of primary hyperalgesia in inflamed joint induced by 3% of carrageenan than ASIC3+/+ mice [17].
###end p 41
###begin p 42
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 97 101 97 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
We did not observe a significant difference in effects of inflammation between ASIC3+/+ and ASIC3-/- mice on pathological examination, which indicates that ASIC3 does not play a role in the development of inflammation, and the difference in hyperalgesia may not be related to the degree of inflammation.
###end p 42
###begin p 43
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 346 352 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.6</italic>
###xml 354 360 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.7</italic>
###xml 366 373 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8 </italic>
###xml 510 516 510 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9</italic>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 616 623 616 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 949 957 949 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1038 1046 1038 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1753 1755 1753 1755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1756 1758 1756 1758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 675 678 <span type="species:ncbi:31658">CFA</span>
###xml 753 756 <span type="species:ncbi:31658">CFA</span>
###xml 1688 1692 <span type="species:ncbi:10090">mice</span>
###xml 1747 1751 <span type="species:ncbi:10116">rats</span>
During inflammation, the enhanced expression of ion channels sensitizes primary afferent neurons and produces hyperexcitability, thereby producing hyperalgesia. Up-regulation of ASIC3 and sodium channels during inflammation have been documented [8-10,23-25]. However, real-time PCR results in our study showed no transcriptional change in ASIC3, Nav1.6, Nav1.7, and Nav1.8 mRNA level following inflammation. These results are contradictory to those in previous studies. The only up-regulated gene we found was Nav1.9, an ion channel reported to be unchanged under intraplantar carrageenan-induced inflammation [25]. Nav1.9 mRNA level has been shown to increase by day 7 with CFA-induced inflammation [26]; however, its expression was not changed in our CFA model. A possible explanation for the discrepancy between our study and previous studies is the difference in sampling and signal quantification. Previous studies used methods such as RT-PCR, in situ hybridization or immunostaining, which were semi-quantitative. Furthermore, both in situ hybridization and immunostaining examine one plane of cells, whereas with real-time PCR, the total mRNAs from all cellular populations in a single DRG were quantified. Lack of transcriptional change in a single DRG by real-time PCR cannot rule out the possibility of up- or down-regulated genes in subgroups of cells or involvement of the gene in posttranscriptional regulation for the process of sensitization. Another issue to consider is the timing of sampling, since regulation of these genes might be transient and time dependent. Animal species and genetic background may also account for the discrepancies to a certain extent, because mice express relatively less ASIC channels in DRGs than do rats [27,28].
###end p 43
###begin p 44
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 154 161 154 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 342 348 342 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9</italic>
###xml 348 352 348 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 469 475 469 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9</italic>
###xml 475 479 475 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 606 612 606 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9</italic>
###xml 612 616 612 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 709 715 709 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9</italic>
###xml 715 719 715 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 765 770 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 770 774 770 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
The up-regulation of Nav1.9 on day 2 with intraplantar carrageenan-induced inflammation was significant and ASIC3 dependent. The functional importance of Nav1.9 in modulation of pain behavior in inflammation has been previously investigated by disrupting the ion channel in mice [29]. Mechanical and thermal thresholds are comparable between Nav1.9-/- and wild-type mice in the absence of injury. In contrast, inflammation-mediated pain behavior differs prominently in Nav1.9-/- mice as compared with wild-type mice. Intraplantar injection of carrageenan induced thermal hyperalgesia in both wild-type and Nav1.9-/- mice in the first 3 h post-injection; however, the hyperalgesia was diminished 24 h later in Nav1.9-/- mice. This finding matches our observation of ASIC3-/- mice with longer paw withdrawal latency starting at 4 h and continuing through day 2, which is indicative of attenuated thermal hyperalgesia.
###end p 44
###begin p 45
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9</italic>
###xml 54 58 54 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 67 71 67 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 136 143 136 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 277 283 277 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9</italic>
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 382 389 382 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
The similar phenotypes in the pain behavior for Nav1.9-/- and ASIC3-/- mice under inflammation and the ASIC3-dependent up-regulation of Nav1.9 suggest that inflammation induces tissue acidosis, which leads to activation of ASIC3 and subsequent ASIC3-dependent up-regulation of Nav1.9; the increased Nav1.9 level in turn contributes to thermal hyperalgesia. In the absence of ASIC3, Nav1.9 cannot be up-regulated, and thermal hyperalgesia becomes attenuated.
###end p 45
###begin p 46
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 65 72 65 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8 </sub>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 262 269 262 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </sub>
###xml 336 343 336 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 415 422 415 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </sub>
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 478 482 478 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 779 786 775 782 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8 </sub>
###xml 1015 1022 1011 1018 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8 </sub>
###xml 1084 1091 1080 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8 </italic>
###xml 1155 1162 1151 1158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8 </sub>
###xml 1186 1188 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1303 1305 1299 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1306 1308 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1342 1349 1338 1345 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8 </sub>
###xml 1526 1528 1522 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1529 1531 1525 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1658 1663 1654 1659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1663 1667 1659 1663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1683 1688 1679 1684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 1688 1692 1684 1688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 1667 1671 <span type="species:ncbi:10090">mice</span>
###xml 1692 1696 <span type="species:ncbi:10090">mice</span>
In contrast to up-regulation of Nav1.9 transcripts, increase of INav1.8 on day 2 with intraplantar carrageenan-induced inflammation was significant and ASIC3 dependent on electrophysiology (Fig. 11). Although our electrophysiolgical data did not show increased INav1.9 in overall small to medium neurons to support the up-regulation of Nav1.9 transcripts during inflammation, we did find a significant increase of INav1.9 in neurons that did not express Nav1.8 activity in ASIC3+/+ mice (65.4 +/- 16.0 vs. 506.5 +/- 147.7 pA for the control vs. carrageenan group, respectively, P < 0.05). Further study would aim to determine whether a specific subset of DRG neurons plays an important role in regulating the ASIC3-dependent effect during inflammation. However, the increase in INav1.8 was robust, with an increase of up to threefold in peak amplitudes, which was associated with maximal mechanical and thermal hyperalgesia on day 2 of carrageenan inflammation. However, a previous study reported slight change of INav1.8 peak amplitude on day 4 of carrageenan inflammation, when the Nav1.8 mRNA was significantly up-regulated and the current density of INav1.8 was slightly increased [24]. Thus, the alteration of Nav1.8 activity during inflammation may be time-dependent, as was seen in many studies [25,30]. Nevertheless, the increase of INav1.8 is intriguing because Nav1.8 is known to play a role in mechanical nociception, and inhibition of Nav1.8 would abolish inflammation-induced mechanical and thermal hyperalgesia [31,32]. Therefore, the increase in Nav1.8 activity may account in part for the carrageenan-induced mechanical hyperalgesia found in ASIC3+/+ mice but not in ASIC3-/- mice.
###end p 46
###begin title 47
Intramuscular inflammation
###end title 47
###begin p 48
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3 </italic>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 156 160 156 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
ASIC3 is critical for the development of secondary mechanical hyperalgesia with muscle inflammation [16]. Our findings agree with this result and show ASIC3+/+ mice with significant mechanical hyperalgesia 2 days after intramuscular carrageenan injection. However, we did not observe thermal hyperalgesia in either genotype with carrageenan-induced inflammation as was reported for C57BL6 mice [16]. Perhaps the time to establish secondary thermal hyperalgesia in CD1 mice is longer than is needed in C57BL6 mice.
###end p 48
###begin p 49
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 25 29 25 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 170 174 170 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 675 678 <span type="species:ncbi:31658">CFA</span>
###xml 939 942 <span type="species:ncbi:10116">rat</span>
###xml 966 969 <span type="species:ncbi:31658">CFA</span>
In inflamed muscle, ASIC3-/- mice seemed to display milder pathological features, including infiltration of leukocytes, formation of granulomas and vasculitis, than ASIC3+/+ mice. Previous reports described the same pathological responses in both genotypes, and an assessment of neutrophilic activity by myeloperoxidase in carrageenan-inflamed muscle also suggested that ASIC3 played no role in the development of inflammation [16]. Although neutrophilic activity represents only one aspect of inflammation, the type of immune cells recruited and their organization and behavior vary by inflammatory conditions. As we examined closely, the inflammation processes involved in CFA- or carrageenan-induced inflammation are not simple. Carrageenan-induced vasculitis was not documented, although in one study histological examination was carried out to characterize the transition of immune cell-type from acute to chronic inflammation of the rat leg muscle [33]. Also, CFA has not been used as a muscle inflammation model; thus, no report of its effect on granuloma formation in muscle exists.
###end p 49
###begin p 50
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
The development of granulomas and vasculitis involves complicated interaction among immune cells, cytokines and chemokines. Granulomas are the aggregation of mononuclear inflammatory cells and modified macrophages organized in a compact nodule, with involvement by a complicated interaction between antigen-presenting macrophages and T lymphocytes mediated by various cytokines [34]. However, the pathogenesis of vasculitis is still not well understood, but endothelium injury is generally believed to be the fundamental event in its development. Responding to neuropeptides (substance P or calcitonin gene-related peptide), endothelial cells mediate several features of chronic inflammation such as vasodilatation, leukocyte migration, cytokine production and cellular adhesion molecule expression [35]. During vascular tone regulation and interaction with immune cells, damage to endothelial cells could occur [36].
###end p 50
###begin p 51
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1123 1124 1123 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1220 1224 <span type="species:ncbi:10090">mice</span>
The involvement of ASIC3, an ion channel present on neurons, in the pathogenesis of these features is thus intriguing. The interplay between the neuronal and immune system has become an interesting topic recently; body systems do not work alone. Neurons could initiate a cascade of cytokine synthesis and release and recruitment of inflammatory machinery. The process is neurogenic inflammation, whereby small-diameter sensory neurons release neuropeptides such as substance P and calcitonin-gene related peptide upon activation. Blocking nerves results in decreasing the inflammation consequences of carrageenan-induced inflammation [37]. ASIC3 could thus participate in the pathogenesis of granuloma formation and vasculitis through activating neurogenic inflammation. Lacking ASIC3 may alter the properties of sensory neurons [38], thus influencing its neurogenic release and the inflammatory consequences. This point should be further investigated. However, the immune system could also affect how the neural system perceives pain through activated mast cells, macrophages, neutrophils, and the cytokines they release [1]. ASIC3-mediated inflammation could be essential for the hyperalgesia we observed in wild-type mice.
###end p 51
###begin title 52
Conclusion
###end title 52
###begin p 53
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 182 186 182 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 195 199 195 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 240 246 240 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3 </italic>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 307 311 307 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 372 376 372 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 671 678 671 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 154 157 <span type="species:ncbi:31658">CFA</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
Here we systematically characterized changes in behavior, pathology, gene expression, and TTX-resistant sodium currents following inflammation induced by CFA and carrageenan in ASIC3-/- and ASIC3+/+ mice and showed that the deletion of the ASIC3 gene affected features in both inflammation models. The ASIC3-/- mice displayed milder symptoms of inflammation than the ASIC3+/+ mice. These findings suggest that ASIC3 mediates the sub-acute phase of primary hyperalgesia produced by inflammation, and the ASIC3-mediated responses to inflammation in the paw differ from those in muscle. ASIC3 participates in the development of sub-acute-phase hyperalgesia by up-regulating Nav1.9 and TTX-R currents in subcutaneous inflammation and mediates the process of granuloma formation or vasculitis in muscular inflammation.
###end p 53
###begin title 54
Methods
###end title 54
###begin title 55
Animals
###end title 55
###begin p 56
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 116 120 116 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 227 231 227 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 240 244 240 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 286 289 286 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
Adult (8- to 12-week-old) female CD1 mice were kept in a 12 h light-dark cycle with sufficient water and food. ASIC3-/- mice were produced as described [15] and backcrossed with CD1 mice for more than 10 generations [28]. ASIC3+/+ and ASIC3-/- mice were offspring of heterozygous (ASIC3+/-) intercrosses. The behavioral experiments and examination of pathology were conducted blinded to animal genotype. All experimental protocols were approved by the Institute of Animal Care and Use Committee of Academia Sinica. Animals were bred and taken care of in accordance with the current Guide for the Use of Laboratory Animals (National Academy Press, Washington DC).
###end p 56
###begin title 57
Inflammatory models
###end title 57
###begin p 58
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 5 9 5 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 27 31 27 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 331 347 330 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 304 307 <span type="species:ncbi:31658">CFA</span>
###xml 331 346 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
###xml 819 823 <span type="species:ncbi:10090">mice</span>
###xml 925 929 <span type="species:ncbi:10090">mice</span>
###xml 1047 1051 <span type="species:ncbi:10090">mice</span>
###xml 1118 1121 <span type="species:ncbi:31658">CFA</span>
###xml 1258 1262 <span type="species:ncbi:10090">mice</span>
ASIC3+/+ (n = 72) and ASIC3-/- (n = 73) mice were divided into 6 groups. Under anesthesia with 2% halothane (Halocarbon laboratory), 3 groups (~18 mice for each) of each genotype were given a single injection of 20 mul saline (pH 7.4, buffered with 20 mM HEPES to rule out the effects of acidic saline), CFA (0.5 mg/ml heat-killed M. tuberculosis [Sigma, St. Louis, MO] suspended in oil:saline 1:1 emulsion) or 3% carrageenan (lambda carrageenan, type IV; Sigma) in the plantar surface of the left hind paw (Day 0) to induce intraplantar inflammation. Behavioral assessments were conducted at 4 h, 1 day, and 2 and 7 days after induction of inflammation, and DRG were harvested at 4 h and days 2 and 7. For this purpose, 6 mice from each group were tested for mechanical responses after 4 h, and then killed; another 6 mice, were tested for behavioral response to pain at days 0, 1 and 2, and then killed at day 2; another 6 mice, for thermal responses 4 h after injection and again for both behavioral assessments at day 7. The other 3 groups (6 mice for each group) of each genotype received an injection of saline, CFA or carrageenan in the left gastrocnemius muscle belly to induce intramuscular inflammation. Behavior was tested at days 0, 1 and 2, and mice were killed on day 2.
###end p 58
###begin title 59
Assessment of thermal and mechanical hyperalgesia
###end title 59
###begin p 60
###xml 224 228 <span type="species:ncbi:10090">mice</span>
Thermal and mechanical sensitivities were tested prior to (day 0) and at 4 h and days 1, 2, and 7 following injections. All tests were performed at constant room temperature of 24degreesC, and stimuli were applied only when mice were calm but not sleeping or grooming. If both tests were performed on the same day, mechanical responses were first assessed, and then thermal tests were performed at least 1 h later.
###end p 60
###begin p 61
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 229 234 <span type="species:ncbi:10090">mouse</span>
For thermal sensitivity assessment, mice were moved to a small cubicle on a glass platform and allowed to habituate for 1 h. The radiant heat source was directed to the plantar surface of one hind paw through the glass until the mouse withdrew its paw. The latency of paw withdrawal from the onset of stimulation was measured sequentially for both hind paws by use of an IITC analgesiometer (IITC Life Sciences, Woodland Hills, CA). The light intensity was set to obtain a baseline response time of approximately 10 sec. The cut-off time was set to 30 sec to minimize heat damage to the skin. Sensitivity of each hind paw was measured with 3 trials, with a 10-min recovery period between each trial. The response was determined by the paw withdrawal latency defined by the mean from 3 trials at each time point.
###end p 61
###begin p 62
###xml 132 136 <span type="species:ncbi:10090">Mice</span>
Mechanical sensitivity was measured by testing the number of responses to stimulation with five applications of von Frey filaments. Mice were placed on an elevated wire mesh platform in a plexi-glass chamber and allowed 1 hr for acclimatization. A von Frey filament of 0.02 g bending force was used as a baseline stimulation. Filaments were briefly applied 5 times to each hind paw, with a 30-sec interval between each application. A response was considered valid with an abrupt foot lift on application of the von Frey filament.
###end p 62
###begin title 63
Examination of pathologic specimens
###end title 63
###begin p 64
###xml 33 34 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 546 549 <span type="species:ncbi:31658">CFA</span>
###xml 1164 1168 <span type="species:ncbi:10090">mice</span>
Mice were sacrificed by use of CO2, and paw thickness was measured at the metatarsal level. The inflamed left hind paw or leg muscle was dissected, fixed in 4% paraformaldehyde overnight and then embedded in paraffin. Paws were decalcified before embedding. Sections were deparaffinized and underwent H&E staining. All sections were examined under a light microscope independently by two pathologists. The inflamed muscle sections were further analyzed by determining the number of granulomas or the percentage of vessels showing vasculitis. For CFA-inflamed muscle, the total area of the muscle cross-sections was determined by use of ImageProPlus software, and the number of well-formed granulomas was counted. A well-formed granuloma was defined as a compact, circumscribed structure with epithelioid macrophages. Vascular changes, including integrity of endothelial lining and vessel wall, perivascular extravasation of erythrocytes, in carrageenan-inflamed muscle were inspected. Infiltration of inflammatory cells, swelling of endothelial cells and apoptotic bodies were used to define vasculitis. These studies were conducted blinded to the genotype of the mice.
###end p 64
###begin title 65
Immunocytochemistry
###end title 65
###begin p 66
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 691 697 <span type="species:ncbi:9986">rabbit</span>
###xml 748 758 <span type="species:ncbi:10141">guinea pig</span>
###xml 936 940 <span type="species:ncbi:9925">goat</span>
###xml 946 952 <span type="species:ncbi:9986">rabbit</span>
###xml 972 976 <span type="species:ncbi:9925">goat</span>
###xml 982 992 <span type="species:ncbi:10141">guinea pig</span>
Mice were anesthetized with an overdose of pentobarbital and intracardially perfused with normal saline followed by 4% paraformaldehyde. The left gastrocnemius muscle was immediately dissected and post-fixed with 4% paraformaldehyde. Post-fixed tissues were placed in 30% sucrose (in pH 7.4 PBS) overnight, then embedded in OCT and rapidly frozen with use of liquid nitrogen and stored at -80degreesC. Frozen sections were cut 20-mum thick on a cryostat and mounted on glass slides. Slides were incubated with blocking solution containing 3% BSA, 0.1% Triton X-100, and 0.02% sodium azide in PBS for 90 min at room temperature. After blocking, slides were incubated with primary antibodies (rabbit anti-ASIC3, 1:500, Alomon Lab, Jerusalem, Israel; guinea pig-anti-PGP9.5, 1:500, Chemicon, Temecula, CA) prepared in blocking solution at 4degreesC overnight. Slides were visualized by use of fluorescence-conjugated secondary antibodies (goat anti-rabbit-Alexa Fluor-488 or goat anti-guinea pig-Alexa Fluor 594, 1:200, Invitrogen, Carlsbad, CA) and mounted on cover slips with DAPI-containing mounting medium (Vector, Burlingame, CA). The ASIC3 staining was eliminated when the control peptides (provided by the manufacture) were applied (data not shown).
###end p 66
###begin title 67
Gene expression in DRG
###end title 67
###begin p 68
###xml 392 395 383 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">18 </sub>
Left and right L1-L5 DRGs were harvested separately and stored at -80degreesC. L1 DRGs were defined as those posterior to the last pair of ribs. Total RNAs of DRGs were isolated by use of the RNeasy mini kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. Each RNA sample was eluted in 30 mul DEPC-treated water. 11 mul from each RNA sample was mixed with 1 mul oligo(dT)18 (250 ng) and 1 mul 10 mM dNTP mix (GeneMark, Taipei, Taiwan), heated to 65degreesC for 5 min and incubated on ice for at least 1 min. 4 mul 5x First-Strand Buffer, 1 mul of 0.1 M DTT, 1 mul RNaseOUT and 1 mul SuperScript III Reverse Transcriptase (Invitrogen, Carlsbad, CA) were then added to the mixture and incubated at 50degreesC for 1 h for reverse transcription (RT). The reaction was inactivated at 70degreesC for 15 min. For real-time PCR, 12.5 mul of 2x SYBR Green PCR Master Mix (ABI, Foster City, CA), and 0.5 mul of the desired primer mixture were added to the RT cDNA templates to a final volume of 25 mul. PCR involved the ABI prism 7700 sequence detector for 95degreesC for 10 min, followed by 40 cycles of 95degreesC for 15 sec, and 60degreesC for 1 min. The primer sequences were as follows:
###end p 68
###begin p 69
ASIC3: F 5'- CCCAGTCCGACTTTTGACAT - 3'
###end p 69
###begin p 70
R 5'- CAGAGTTGAAGGTGTAGCAT - 3'
###end p 70
###begin p 71
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
Nav1.6: F 5' - CCGATGGAAGAACGTCAAGA - 3'
###end p 71
###begin p 72
R 5' - ATAATCAGGCTGCTCGTCCG - 3'
###end p 72
###begin p 73
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
Nav1.7: F 5'- GACCTTGGCCCCATTAAATCT - 3'
###end p 73
###begin p 74
R 5'- CTTGCCAGCAAACAGATTGAC - 3'
###end p 74
###begin p 75
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
Nav1.8: F 5' - GTAGTGGTGGATGCCTTGGT - 3'
###end p 75
###begin p 76
R 5'- AAGTGGCCGGTATTGTTTTG - 3'
###end p 76
###begin p 77
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
Nav1.9: F 5'- GATGTGCCCAAGATCAAGGT - 3'
###end p 77
###begin p 78
R 5'- TTCCGACGTTCAATCTTTCC - 3'
###end p 78
###begin p 79
TRPV1: F 5' - TCTCCACTGGTGTTGAGACG
###end p 79
###begin p 80
R 5' - GGGTCTTTGAACTCGCTGTC
###end p 80
###begin p 81
GAPDH: F 5'- GGAGCCAAACGGGTCATCATCTC - 3'
###end p 81
###begin p 82
R 5' - GAGGGGCCATCCACAGTCTTCT - 3'
###end p 82
###begin title 83
Electrophysiology
###end title 83
###begin p 84
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 307 308 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 322 324 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 465 466 465 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 474 475 474 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 485 486 485 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 802 804 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1037 1039 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
DRG neurons of lumbar 5 segments were isolated from mice treated with intraplantar saline or carrageenan for 2 days. DRG acute culture and settings for whole-cell patch recording were as previously described [28]. The internal solution contained (in mM) 10 NaCl, 110 CsCl, 20 tetraethylammonium-Cl, 2.5 MgCl2, 5 EGTA, 3 Mg2+-ATP, and 5 HEPES, adjusted to pH 7.0 with CsOH. The external solution contained (in mM) 100 NaCl, 5 CsCl, 30 tetraethylammonium-Cl, 1.8 CaCl2, 1 MgCl2, 0.1 CdCl2, 25 glucose, 5 4-aminopyridine, and 5 HEPES, adjusted to pH 7.4 with HCl. Osmolarity was adjusted to 290 mosmol/kg with glucose. Before whole-cell patch recording, cells were stained for isolectin B4(IB4)-FITC (4 mug/ml) for 2 min, and only small- to medium-size (< 34 mum) DRG neurons were selected for recording [28]. Recordings were performed in external solution containing 200 nM TTX (Tocris, Avonmouth, UK). TTX-resistant sodium currents were evoked by a 30-ms test pulse between -70 and 0 mV in 10-mV steps from a holding potential of -80 mV [20]. For clarity, only the -60 and -40 mV current traces were shown. All recording was at room temperature (21-25degreesC) and completed within 24 h after plating. A total of 144 DRG neurons were patch recorded; half of them were IB4-positive neurons.
###end p 84
###begin title 85
Statistics
###end title 85
###begin p 86
Data are expressed as mean +/- SEM. Analysis involved use of SAS9.1 (SAS Inst, Cary, NC). Radiant heat testing was analyzed by two-way ANOVA followed by least squares means post-hoc test. Mann-Whitney U-test was used to determine differences in mechanical sensitivity between groups and time points, differences in paw thickness, granuloma, vasculitis, and quantitative PCR. Mean peak amplitudes of TTX-R currents were compared between groups via one-way ANOVA. The level of significance was set at P < 0.05.
###end p 86
###begin title 87
Abbreviations
###end title 87
###begin p 88
###xml 62 65 <span type="species:ncbi:31658">CFA</span>
ASIC3: acid-sensing ion channel 3; DRG: dorsal root ganglion; CFA: complete Freund's adjuvant; Nav: voltage-gated sodium channel; TRPV1: capsaicin receptor; TTX: tetrodotoxin.
###end p 88
###begin title 89
Competing interests
###end title 89
###begin p 90
The authors declare that they have no competing interests.
###end p 90
###begin title 91
Authors' contributions
###end title 91
###begin p 92
###xml 159 164 <span type="species:ncbi:10090">mouse</span>
YTY performed pain behavior testing, pathological examination, and quantitative PCR. PHT and STH examined and interpreted the pathological data. CJC performed mouse genotyping, analyzed the pathological & behavioral data, and performed immunocytochemistry. YWL performed the electrophysiology. CCC oversaw the research and prepared the manuscript with help from all others.
###end p 92
###begin title 93
Supplementary Material
###end title 93
###begin title 94
Additional file 1
###end title 94
###begin p 95
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inflammation-mediated hyperalgesia in the contralateral paws.</bold>
###xml 321 326 321 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 326 330 326 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 366 370 366 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 466 471 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 471 475 471 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 479 484 479 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 484 488 484 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
Inflammation-mediated hyperalgesia in the contralateral paws. A, Thermal hyperalgesia results of intraplantar inflammation. B, von Frey filament test results of intraplantar inflammation. C, Thermal hyperalgesia results of intramuscular inflammation. D, von Frey filament tests results of intramuscular inflammation. WT: ASIC3+/+ mice, n = 6 in each group. KO: ASIC3-/- mice, n = 6 in each group. *p < 0.05 compared to baseline latency. #p < 0.05 comparison between ASIC3+/+ and ASIC3-/- groups.
###end p 95
###begin p 96
Click here for file
###end p 96
###begin title 97
Additional file 2
###end title 97
###begin p 98
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 30 34 30 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gene expression level in <italic>ASIC3</italic><sup>+/+ </sup>DRG 2 days after induction of inflammation.</bold>
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.6</italic>
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.7</italic>
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8</italic>
###xml 126 133 126 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 137 143 137 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRPV1 </italic>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASIC3</italic>
###xml 237 243 237 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.6</italic>
###xml 245 251 245 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.7</italic>
###xml 253 259 253 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.8</italic>
###xml 261 268 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nav1.9 </italic>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRPV1 </italic>
Gene expression level in ASIC3+/+ DRG 2 days after induction of inflammation. A, Expression of ASIC3, Nav1.6, Nav1.7, Nav1.8, Nav1.9 and TRPV1 2 days after intraplantar carrageenan-induced inflammation in L5 DRG. B, Expression of ASIC3, Nav1.6, Nav1.7, Nav1.8, Nav1.9 and TRPV1 2 days after intramuscular inflammation induction in L4 DRG. *p < 0.05 compared with saline group of the same side.
###end p 98
###begin p 99
Click here for file
###end p 99
###begin title 100
Acknowledgements
###end title 100
###begin p 101
The work was supported by National Science Council grants NSC 93-2320-B-001-047, NSC 94-2320-B-001-039 and NSC 96-2311-B-001-041-MY2. We thank Dr. Takeki Kikuchi for help in pathological examination and Mr. Shing-Hong Lin for help in statistics.
###end p 101
###begin article-title 102
Role of the immune system in chronic pain
###end article-title 102
###begin article-title 103
Molecular physiology of proton transduction in nociceptors
###end article-title 103
###begin article-title 104
Acid-sensing ion channels in sensory perception
###end article-title 104
###begin article-title 105
H(+)-gated cation channels: neuronal acid sensors in the NaC/DEG family of ion channels
###end article-title 105
###begin article-title 106
Lactate enhances the acid-sensing Na+ channel on ischemia-sensing neurons
###end article-title 106
###begin article-title 107
###xml 58 61 <span type="species:ncbi:10116">rat</span>
Arachidonic acid potentiates acid-sensing ion channels in rat sensory neurons by a direct action
###end article-title 107
###begin article-title 108
Modulation of acid-sensing ion channel activity by nitric oxide
###end article-title 108
###begin article-title 109
###xml 54 59 <span type="species:ncbi:9606">human</span>
Increased acid-sensing ion channel ASIC-3 in inflamed human intestine
###end article-title 109
###begin article-title 110
Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors
###end article-title 110
###begin article-title 111
Osteoclasts play a part in pain due to the inflammation adjacent to bone
###end article-title 111
###begin article-title 112
Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants
###end article-title 112
###begin article-title 113
Evidence for neurogenic transmission inducing degenerative cartilage damage distant from local inflammation
###end article-title 113
###begin article-title 114
###xml 68 71 <span type="species:ncbi:10116">rat</span>
Pathway to carrageenan-induced inflammation in the hind limb of the rat
###end article-title 114
###begin article-title 115
###xml 94 98 <span type="species:ncbi:10090">mice</span>
The DRASIC cation channel contributes to the detection of cutaneous touch and acid stimuli in mice
###end article-title 115
###begin article-title 116
A role for ASIC3 in the modulation of high-intensity pain stimuli
###end article-title 116
###begin article-title 117
ASIC3 in muscle mediates mechanical, but not heat, hyperalgesia associated with muscle inflammation
###end article-title 117
###begin article-title 118
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Role of ASIC3 in the primary and secondary hyperalgesia produced by joint inflammation in mice
###end article-title 118
###begin article-title 119
ASIC3, an acid-sensing ion channel, is expressed in metaboreceptive sensory neurons
###end article-title 119
###begin article-title 120
Effects of decompression on neuropathic pain behaviors and skin reinnervation in chronic constriction injury
###end article-title 120
###begin article-title 121
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Prostaglandin E2 has no effect on two components of tetrodotoxin-resistant Na+ current in mouse dorsal root ganglion
###end article-title 121
###begin article-title 122
Transgenic expression of a dominant-negative ASIC3 subunit leads to increased sensitivity to mechanical and inflammatory stimuli
###end article-title 122
###begin article-title 123
ASIC3, a sensor of acidic and primary inflammatory pain
###end article-title 123
###begin article-title 124
Rapid sodium channel augmentation in response to inflammation induced by complete Freund's adjuvant
###end article-title 124
###begin article-title 125
SNS Na+ channel expression increases in dorsal root ganglion neurons in the carrageenan inflammatory pain model
###end article-title 125
###begin article-title 126
Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain
###end article-title 126
###begin article-title 127
Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons
###end article-title 127
###begin article-title 128
###xml 153 157 <span type="species:ncbi:10116">rats</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
The role of the capsaicin receptor TRPV1 and acid-sensing ion channels (ASICS) in proton sensitivity of subpopulations of primary nociceptive neurons in rats and mice
###end article-title 128
###begin article-title 129
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Identification and characterization of a subset of mouse sensory neurons that express acid-sensing ion channel 3
###end article-title 129
###begin article-title 130
Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior
###end article-title 130
###begin article-title 131
###xml 119 122 <span type="species:ncbi:10116">rat</span>
Changes in the expression of NaV1.7, NaV1.8 and NaV1.9 in a distinct population of dorsal root ganglia innervating the rat knee joint in a model of chronic inflammatory joint pain
###end article-title 131
###begin article-title 132
The cell and molecular basis of mechanical, cold, and inflammatory pain
###end article-title 132
###begin article-title 133
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
###end article-title 133
###begin article-title 134
###xml 96 100 <span type="species:ncbi:10116">rats</span>
Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats
###end article-title 134
###begin article-title 135
Granuloma formation, implications for the pathogenesis of vasculitis
###end article-title 135
###begin article-title 136
Neuropeptides and endothelial injury in cutaneous vasculitis
###end article-title 136
###begin article-title 137
###xml 30 35 <span type="species:ncbi:9606">human</span>
Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation
###end article-title 137
###begin article-title 138
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Effect of neurolytic nerve block on systemic carrageenan-induced inflammatory response in mice
###end article-title 138
###begin article-title 139
Nociceptors of dorsal root ganglion express proton-sensing G-protein-coupled receptors
###end article-title 139

